Ropivacaine

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

53 Suppliers, 16 USDMF, 9 CEP/COS, 1 JDMF, 11 EU WC, 5 KDMF, 12 NDC API, 38 Listed Suppliers

DEVELOPMENTS

8 Drug(s) in Development

8 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

10 Suppliers

10 Suppliers

DOSSIERs // Finished Dosage Forms

145 Dossiers, 63 FDA Orange Book, 48 Europe, 6 Canada, 11 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;INJECTION - 100MG/10ML (10MG/ML), SOLUTION;INJECTION - 100MG/20ML (5MG/ML), SOLUTION;INJECTION - 150MG/30ML (5MG/ML), SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML), SOLUTION;INJECTION - 1GM/200ML (5MG/ML), SOLUTION;INJECTION - 200MG/20ML (10MG/ML), SOLUTION;INJECTION - 200MG/100ML (2MG/ML), SOLUTION;INJECTION - 20MG/10ML (2MG/ML), SOLUTION;INJECTION - 400MG/200ML (2MG/ML), SOLUTION;INJECTION - 40MG/20ML (2MG/ML), SOLUTION;INJECTION - 500MG/100ML (5MG/ML), SOLUTION;INJECTION - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INJECTION - 75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 3 Actylis

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 25 Finished Drug Prices

MARKET PLACE

15 APIs, 2 DOSSIERS // FDF

PATENTS

6 US Patents, 14 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 3 USP Standards, 15 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 28 News

Information, Expiry & Status of FDA Orange Book Patents covering Ropivacaine

Ropivacaine

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

53 Suppliers

16 USDMF

9 CEP/COS

1 JDMF

11 EU WC

5 KDMF

12 NDC API

38 Listed Suppliers

DEVELOPMENTS

8 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

10 Suppliers

DOSSIERs // Finished Dosage Forms

145 Dossiers

63 FDA Orange Book

48 Europe

6 Canada

11 South Africa

17 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;INJECTION - 100MG/10ML (10MG/ML)

SOLUTION;INJECTION - 100MG/20ML (5MG/ML)

SOLUTION;INJECTION - 150MG/30ML (5MG/ML)

SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML)

SOLUTION;INJECTION - 1GM/200ML (5MG/ML)

SOLUTION;INJECTION - 200MG/20ML (10MG/ML)

SOLUTION;INJECTION - 200MG/100ML (2MG/ML)

SOLUTION;INJECTION - 20MG/10ML (2MG/ML)

SOLUTION;INJECTION - 400MG/200ML (2MG/ML)

SOLUTION;INJECTION - 40MG/20ML (2MG/ML)

SOLUTION;INJECTION - 500MG/100ML (5MG/ML)

SOLUTION;INJECTION - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INJECTION - 75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

3 Actylis

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

25 Finished Drug Prices

MARKET PLACE

15 APIs

2 DOSSIERS // FDF

PATENTS

6 US Patents

14 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 EDQM Standards

3 USP Standards

15 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow

28 News

Y

2026-11-28

20533

6

Y

2024-05-23

20533

7

Y

2024-05-23

20533

6

Y

2025-10-18

20533

7

Y

2025-10-18

20533

SOLUTION;INJECTION - 50MG/10ML (5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INJECTION - 75MG/10ML (7.5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons